156 related articles for article (PubMed ID: 9860926)
1. Multiple activated oxygen species in P450 catalysis: contributions To specificity in drug metabolism.
Coon MJ; Vaz AD; McGinnity DF; Peng HM
Drug Metab Dispos; 1998 Dec; 26(12):1190-3. PubMed ID: 9860926
[TBL] [Abstract][Full Text] [Related]
2. Ipso-substitution by cytochrome P450 with conversion of p-hydroxybenzene derivatives to hydroquinone: evidence for hydroperoxo-iron as the active oxygen species.
Vatsis KP; Coon MJ
Arch Biochem Biophys; 2002 Jan; 397(1):119-29. PubMed ID: 11747318
[TBL] [Abstract][Full Text] [Related]
3. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.
Vaz AD; Pernecky SJ; Raner GM; Coon MJ
Proc Natl Acad Sci U S A; 1996 May; 93(10):4644-8. PubMed ID: 8643457
[TBL] [Abstract][Full Text] [Related]
4. Epoxidation of olefins by cytochrome P450: evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant.
Vaz AD; McGinnity DF; Coon MJ
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3555-60. PubMed ID: 9520404
[TBL] [Abstract][Full Text] [Related]
5. Highly reactive electrophilic oxidants in cytochrome P450 catalysis.
Newcomb M; Chandrasena RE
Biochem Biophys Res Commun; 2005 Dec; 338(1):394-403. PubMed ID: 16168951
[TBL] [Abstract][Full Text] [Related]
6. Models and mechanisms of O-O bond activation by cytochrome P450. A critical assessment of the potential role of multiple active intermediates in oxidative catalysis.
Hlavica P
Eur J Biochem; 2004 Nov; 271(22):4335-60. PubMed ID: 15560776
[TBL] [Abstract][Full Text] [Related]
7. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
de Visser SP; Shaik S
J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
[TBL] [Abstract][Full Text] [Related]
8. Discrete species of activated oxygen yield different cytochrome P450 heme adducts from aldehydes.
Kuo CL; Raner GM; Vaz AD; Coon MJ
Biochemistry; 1999 Aug; 38(32):10511-8. PubMed ID: 10441147
[TBL] [Abstract][Full Text] [Related]
9. Kinetic isotope effects implicate two electrophilic oxidants in cytochrome p450-catalyzed hydroxylations.
Newcomb M; Aebisher D; Shen R; Chandrasena RE; Hollenberg PF; Coon MJ
J Am Chem Soc; 2003 May; 125(20):6064-5. PubMed ID: 12785830
[TBL] [Abstract][Full Text] [Related]
10. Oxidative deboronation of the peptide boronic acid proteasome inhibitor bortezomib: contributions from reactive oxygen species in this novel cytochrome P450 reaction.
Labutti J; Parsons I; Huang R; Miwa G; Gan LS; Daniels JS
Chem Res Toxicol; 2006 Apr; 19(4):539-46. PubMed ID: 16608165
[TBL] [Abstract][Full Text] [Related]
11. Peroxo-iron mediated deformylation in sterol 14alpha-demethylase catalysis.
Sen K; Hackett JC
J Am Chem Soc; 2010 Aug; 132(30):10293-305. PubMed ID: 20662512
[TBL] [Abstract][Full Text] [Related]
12. EPR spectrometry of cytochrome P450 2B4: effects of mutations and substrate binding.
LeLean JE; Moon N; Dunham WR; Coon MJ
Biochem Biophys Res Commun; 2000 Sep; 276(2):762-6. PubMed ID: 11027544
[TBL] [Abstract][Full Text] [Related]
13. Multiple oxidants in cytochrome P450 catalyzed reactions: implications for drug metabolism.
Vaz AD
Curr Drug Metab; 2001 Mar; 2(1):1-16. PubMed ID: 11465148
[TBL] [Abstract][Full Text] [Related]
14. Formation of a novel reversible cytochrome P450 spectral intermediate: role of threonine 303 in P450 2E1 inactivation.
Blobaum AL; Lu Y; Kent UM; Wang S; Hollenberg PF
Biochemistry; 2004 Sep; 43(38):11942-52. PubMed ID: 15379534
[TBL] [Abstract][Full Text] [Related]
15. The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity.
Nelson SD; Trager WF
Drug Metab Dispos; 2003 Dec; 31(12):1481-98. PubMed ID: 14625345
[TBL] [Abstract][Full Text] [Related]
16. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
Lewis DF; Jacobs MN; Dickins M
Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
[TBL] [Abstract][Full Text] [Related]
17. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
[TBL] [Abstract][Full Text] [Related]
18. The role of the conserved threonine in P450 BM3 oxygen activation: substrate-determined hydroxylation activity of the Thr268Ala mutant.
Cryle MJ; De Voss JJ
Chembiochem; 2008 Jan; 9(2):261-6. PubMed ID: 18161730
[TBL] [Abstract][Full Text] [Related]
19. Multiple oxidants and multiple mechanisms in cytochrome P450 catalysis.
Coon MJ
Biochem Biophys Res Commun; 2003 Dec; 312(1):163-8. PubMed ID: 14630036
[No Abstract] [Full Text] [Related]
20. Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome p450 enzymes.
Lanza DL; Yost GS
Drug Metab Dispos; 2001 Jul; 29(7):950-3. PubMed ID: 11408359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
